{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:29:56Z","timestamp":1791160196735,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.autrev.2006.03.012","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T11:12:54Z","timestamp":1147000374000},"page":"486-492","source":"Crossref","is-referenced-by-count":84,"title":["Therapeutic implications of autoimmune vitiligo T cells"],"prefix":"10.1016","volume":"5","author":[{"given":"Kepa","family":"Oyarbide-Valencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper G.","family":"van den Boorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecele J.","family":"Denman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie M.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Caroline","family":"Le Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2006.03.012_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation","volume":"100","author":"Le Poole","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.2005.01813.x","article-title":"Clinical profiles of vitiligo in China: an analysis of 3742 patients","volume":"30","author":"Liu","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-4632.2004.01948.x","article-title":"Late onset vitiligo: a study of 182 patients","volume":"44","author":"Dogra","year":"2005","journal-title":"Int J Dermatol"},{"issue":"S6","key":"10.1016\/j.autrev.2006.03.012_bib4","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1067\/mjd.2003.274","article-title":"Ethnic skin disorders overview","volume":"48","author":"Halder","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.det.2005.05.007","article-title":"Stigma experience in skin disorders: an Indian perspective","volume":"23","author":"Chaturvedi","year":"2005","journal-title":"Dermatol Clin"},{"issue":"11","key":"10.1016\/j.autrev.2006.03.012_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-4632.2004.02059.x","article-title":"What patients with vitiligo believe about their condition","volume":"43","author":"Firooz","year":"2004","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1242\/dev.115.4.1111","article-title":"TRP-2\/DT, a new early melanoblast marker, shows that steel factor (ckit ligand) is a survival factor","volume":"115","author":"Steel","year":"1992","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2230.2004.01536.x","article-title":"Psoralens plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin","volume":"29","author":"Abdel Naser","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2006.03.012_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2006.03.012_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2006.03.012_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2006.03.012_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2006.03.012_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"Van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.autrev.2006.03.012_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00370733","article-title":"Reappraisal of in situ immunophenotypic analysis of psoriatic skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions","volume":"286","author":"De Boer","year":"1994","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12480976","article-title":"Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients","volume":"97","author":"Boissy","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2006.03.012_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-4362.1994.tb02895.x","article-title":"Biologic characteristics of cultured human melanocytes","volume":"33","author":"Im","year":"1994","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\/occupational vitiligo","volume":"17","author":"Boissy","year":"2004","journal-title":"Pigment Cell Res"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.03.012_bib19","first-page":"34","article-title":"Stress proteins and initiation of immune response: chaperone activity of hsp72","volume":"11","author":"Asea","year":"2005","journal-title":"Exerc Immunol Rev"},{"issue":"9","key":"10.1016\/j.autrev.2006.03.012_bib20","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.167.9.4844","article-title":"Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells","volume":"167","author":"Somersan","year":"2001","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2006.03.012_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment with interferon","volume":"254","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1016\/j.autrev.2006.03.012_bib22","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1200\/JCO.2005.01.6816","article-title":"Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients","volume":"23","author":"Luiten","year":"2005","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.autrev.2006.03.012_bib23","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1074\/jbc.M413692200","article-title":"MART-1 is required for the function of the melanosomal matrix protein Pmel17\/gp100 and the maturation of melanosomes","volume":"230","author":"Hoashi","year":"2005","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2006.03.012_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/08830189709116851","article-title":"Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy","volume":"14","author":"Kawakami","year":"1997","journal-title":"Int Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2006.03.012_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrfmmm.2004.09.014","article-title":"MC1R and the response of melanocytes to ultraviolet radiation","volume":"571","author":"Rouzaud","year":"2005","journal-title":"Mutat Res"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1615\/CritRevImmunol.v25.i3.30","article-title":"Dendritic cell-derived exosomes as cell-free peptide-based vaccines","volume":"25","author":"Taieb","year":"2005","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2006.03.012_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1523-1747.ep12354138","article-title":"Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis","volume":"100","author":"Orlow","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2000.03712.x","article-title":"Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo","volume":"143","author":"van den Wijngaard","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2006.03.012_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-642-78771-3_11","article-title":"Production of cytokines by human melanoma cells and melanocytes","volume":"139","author":"Kruger-Krasagakes","year":"1995","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"10.1016\/j.autrev.2006.03.012_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/excr.1993.1102","article-title":"Phagocytosis by normal human melanocytes in vitro","volume":"205","author":"Le Poole","year":"1993","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/j.autrev.2006.03.012_bib31","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2006.03.012_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevImmunol.v20.i6.10","article-title":"Autoimmunity and immunotherapy of cancer: targeting the \u2018self\u2019 to destroy the \u2018other\u2019","volume":"20","author":"Overwijk","year":"2000","journal-title":"Crit Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib33","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.autrev.2006.03.012_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.autrev.2006.03.012_bib35","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.0831229100","article-title":"Reversal of developmental restrictions in neural crest lineages: transition from Schwann cells to glial-melanocytic precursors in vitro","volume":"100","author":"Dupin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.2003.05539.x","article-title":"Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin","volume":"149","author":"Le Poole","year":"2003","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo","volume":"22","author":"Das","year":"2001","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2006.03.012_bib38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-05-1485","article-title":"Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma","volume":"12","author":"Duval","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.autrev.2006.03.012_bib39","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/eji.200535110","article-title":"Qualitative difference between the cytotoxic T-lymphocyte responses to melanocyte antigens in melanoma and vitiligo","volume":"35","author":"Palermo","year":"2005","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2006.03.012_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T10:16:59Z","timestamp":1683454619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1568997206000449"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.03.012","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}